A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE
Our Community Bookmark and Share

City of Hope is turning science into practical benefit…For our current and future patients and our community

City of Hope Leads the Way in Research  
 
Jeffrey Weitzel, M.D. is Chief of the Division of Clinical Cancer Genetics at City of Hope. Dr. Weitzel's multidisciplinary clinical and research program emphasizes the recognition and assessment of people at increased risk for developing cancer because of family cancer history or personal risk factors. He is currently studying the incidence of breast cancer in Latina women. Learn more about Dr. Weitzel.
 
Amrita Krishnan, M.D., F.A.C.P., is Director of the Multiple Myeloma Program at City of Hope. Her work highlights the need for personalization in the treatment of multiple myeloma — the key is to tailor the therapy in the most appropriate way. Learn more about Dr. Krishnan.
 
Reducing Health Disparities
 
Population Sciences
The mission of the Department of Population Sciences is to advance the science and application of cancer etiology, prevention and outcomes, and reduce the burden of cancer and its sequelae across all populations, through collaborative multidisciplinary programs in clinical service, research and education. It’s divisions include Cancer Etiology, Center for Cancer Survivorship, CCARE, Clinical Cancer Genetics, Nursing Research and Education, Outcomes Research, and BMT Study.
 
Center of Community Alliance for Research and Education
CCARE implements specific best practice community strategies to reduce and eliminate inequalities in cancer outcomes. Our mission is to increase education and awareness of the most advanced practices in health care for all patients, bringing the best that City of Hope has to offer to underrepresented and underserved patients and communities.
 
Clinical Trials
At any given time, our researchers are conducting hundreds of clinical trials to test new treatments for cancer. Recruiting diverse participants to these trials allows us to better understand how cancer and its treatments impact different communities and people differently. Our clinical trials improve health.
 
Serving Our Latino Community
 
Given that cancer is the leading cause of death among Latinos in California, and recognizing that our primary service area is 46% Latino, we are taking more active steps to better understand and serve the Latino community.

Learn more about the current initiatives at City of Hope aimed at connecting with our Latino community.
 
City of Hope Celebrates Hispanic Heritage Month
 
 
Here are some of the thoughts and feelings of our Latino employees. It couldn't be said any better:
"Not only does City of Hope support but encourages diversity."

"It's not just one size fits all, you can make it what you want it to be."

"I have a passion for learning… at City of Hope there are so many things to learn everyday."

"You're surrounded by the best minds this stimulates you to become the best scientist."

"You are part of an organization that impacts people daily, and we are changing lives, not only of the patient but of their entire family."

" ...everyone is there to do something amazing and support each other, it’s refreshing, extremely rare and absolutely unique."
 
Together, we are hope - #TogetherWeAreHope
 
Contact us at diversityandinclusion@coh.org for more information.

Our Community

City of Hope is turning science into practical benefit…For our current and future patients and our community

City of Hope Leads the Way in Research  
 
Jeffrey Weitzel, M.D. is Chief of the Division of Clinical Cancer Genetics at City of Hope. Dr. Weitzel's multidisciplinary clinical and research program emphasizes the recognition and assessment of people at increased risk for developing cancer because of family cancer history or personal risk factors. He is currently studying the incidence of breast cancer in Latina women. Learn more about Dr. Weitzel.
 
Amrita Krishnan, M.D., F.A.C.P., is Director of the Multiple Myeloma Program at City of Hope. Her work highlights the need for personalization in the treatment of multiple myeloma — the key is to tailor the therapy in the most appropriate way. Learn more about Dr. Krishnan.
 
Reducing Health Disparities
 
Population Sciences
The mission of the Department of Population Sciences is to advance the science and application of cancer etiology, prevention and outcomes, and reduce the burden of cancer and its sequelae across all populations, through collaborative multidisciplinary programs in clinical service, research and education. It’s divisions include Cancer Etiology, Center for Cancer Survivorship, CCARE, Clinical Cancer Genetics, Nursing Research and Education, Outcomes Research, and BMT Study.
 
Center of Community Alliance for Research and Education
CCARE implements specific best practice community strategies to reduce and eliminate inequalities in cancer outcomes. Our mission is to increase education and awareness of the most advanced practices in health care for all patients, bringing the best that City of Hope has to offer to underrepresented and underserved patients and communities.
 
Clinical Trials
At any given time, our researchers are conducting hundreds of clinical trials to test new treatments for cancer. Recruiting diverse participants to these trials allows us to better understand how cancer and its treatments impact different communities and people differently. Our clinical trials improve health.
 
Serving Our Latino Community
 
Given that cancer is the leading cause of death among Latinos in California, and recognizing that our primary service area is 46% Latino, we are taking more active steps to better understand and serve the Latino community.

Learn more about the current initiatives at City of Hope aimed at connecting with our Latino community.
 
City of Hope Celebrates Hispanic Heritage Month
 
 
Here are some of the thoughts and feelings of our Latino employees. It couldn't be said any better:
"Not only does City of Hope support but encourages diversity."

"It's not just one size fits all, you can make it what you want it to be."

"I have a passion for learning… at City of Hope there are so many things to learn everyday."

"You're surrounded by the best minds this stimulates you to become the best scientist."

"You are part of an organization that impacts people daily, and we are changing lives, not only of the patient but of their entire family."

" ...everyone is there to do something amazing and support each other, it’s refreshing, extremely rare and absolutely unique."
 
Together, we are hope - #TogetherWeAreHope
 
Contact us at diversityandinclusion@coh.org for more information.
We're a community of people characterized by our diversity of thought, background and approach.
 
We have career opportunities in nursing, research, allied health, business support and many other areas.
 
City of Hope employees enjoy excellent benefits and an environment that inspires wellness.
 
In addition to our main campus in Duarte, CA, we have several locations throughout the Los Angeles vicinity.
 
Current employees and external candidates are invited to explore our career opportunities.
 
City of Hope is a community of people characterized by our diversity of thought, background, and approach, but tied together by our commitment to care for and cure those with cancer and other life-threatening diseases. Download our Diversity & Inclusion brochure.
Learn more about City of Hope's institutional distinctions, breakthrough innovations and collaborations.


NEWS & UPDATES
  • It was 2009 when a City of Hope patient in her 40s learned that the cancer she had been fighting for several years had metastasized to her lungs. Her medical team ran genetic tests on the tumor, but none of the drug therapies available at the time targeted the known mutations in the tumor cells. […]
  • Acute myeloid leukemia (AML) is characterized by a rapidly-developing cancer in the myeloid line of blood cells, which is responsible for producing red blood cells, platelets and several types of white blood cells called granulocytes. Because AML grows rapidly, it can quickly crowd out normal blood cells, leadi...
  • Rachel Divine is a yoga therapist and patient leader for the Sheri & Les Biller Patient and Family Resource Center. She’s also a former City of Hope patient. When someone you know has cancer, even the word “cancer” can make you feel nervous, sleepless, depressed or more. But, as a yoga teacher for 15 ...
  •   Diagnosed with type 1 diabetes when she was 9 years old, Gina Marchini accepted the fact that she would need insulin the rest of her life. Every day, she injected herself with the lifesaving hormone. She also carefully controlled her diet and monitored the rise and fall of her blood glucose with military...
  • The defeat of cancer will require a team effort. Nowhere is this more necessary (or apparent) than in efforts to combat two of the most deadly forms of the disease  – pancreatic cancer and triple-negative breast cancer. It’s the approach City of Hope is taking with its newly launched multidisciplinary teams, br...
  • It’s a reasonable question: Why is the National Cancer Institute funding a study on preventing heart failure? The answer is reasonable as well: Rates of heart failure are drastically high among childhood cancer survivors — 15 times higher than among people the same age who were never treated for cancer. T...
  • Many teenagers take a break from academics during the summer, but not the eight high school students enrolled in the California Institute for Regenerative Medicine (CIRM) Creativity Awards program at City of Hope. They took the opportunity to obtain as much hands-on research experience as possible, learning fro...
  • About one in eight women will develop breast cancer at some point in her life. In fact, breast cancer is the most common cancer in American women, behind skin cancer. Although women can’t change some risk factors, such as genetics and the natural aging process, there are certain things they can do to lower thei...
  • As genetic testing becomes more sophisticated, doctors and their patients are finding that such tests can lead to the discovery of previously unknown cancer risks. In his practice at City of Hope, Thomas Slavin, M.D., an assistant clinical professor in the Division of Clinical Cancer Genetics, sees the full spe...
  • And the winners are … everyone in the San Gabriel Valley. The recipients of City of Hope’s first-ever Healthy Living grants have been announced, and the future is looking healthier already. In selecting San Gabriel Valley organizations to receive the grants, City of Hope’s Community Benefits Advisory Council ch...
  • Barry Leshowitz is a former City of Hope patient and a family advisor for the Sheri & Les Biller Patient and Family Resource Center. It’s been almost seven years since I checked into a local hospital in Phoenix for a hip replacement, only to be informed by the surgeon that he had canceled the surgery....
  • When it comes to science, the best graduate schools don’t just train scientists, they prepare their students for a lifetime of learning, accomplishment and positive impact on society. At City of Hope, the Irell & Manella Graduate School of Biological Sciences goes one step further – by preparing students to...
  • Cancer affects not just the cancer patient, but everyone around him or her, even after treatment is complete. The challenges can include the fear of cancer recurrence, coping with cancer’s economic impact and the struggle to achieve work-life balance post-treatment. Family members and loved ones of cancer patie...
  •   Bladder cancer facts: Bladder cancer is a disease in which malignant (cancer) cells form in the tissues of the bladder. 2015 estimates: 74,000 new cases of bladder cancer diagnosed 16,000 deaths from bladder cancer (about 11,510 in men and 4,490 in women) Risk factors for bladder cancer: Smoking: Smokers...
  • Women with ovarian cancer have questions about the most promising treatment options, revolutionary research avenues, survivorship and, of course, the potential impact on their personal lives. Now, together in one place, are experts who can provide answers. On Saturday, Sept. 12, the 2015 Ovarian Cancer Survivor...